International consensus on (ICON) pediatric asthma
Top Cited Papers
Open Access
- 15 June 2012
- Vol. 67 (8), 976-997
- https://doi.org/10.1111/j.1398-9995.2012.02865.x
Abstract
Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re‐evaluate and fine‐tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype‐specific treatment choices; however, this goal has not yet been achieved.Keywords
This publication has 133 references indexed in Scilit:
- Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokinesJournal of Allergy and Clinical Immunology, 2012
- Development and comorbidity of eczema, asthma and rhinitis to age 12 – data from the BAMSE birth cohortAllergy, 2012
- Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescentsJournal of Allergy and Clinical Immunology, 2012
- Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasoneJournal of Allergy and Clinical Immunology, 2011
- Advancing asthma care: The glass is only half full!Journal of Allergy and Clinical Immunology, 2011
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaCochrane Database of Systematic Reviews, 2010
- Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled CorticosteroidsNew England Journal of Medicine, 2010
- Predictors of remitting, periodic, and persistent childhood asthmaJournal of Allergy and Clinical Immunology, 2010
- Long-Term Budesonide or Nedocromil Treatment, Once Discontinued, Does Not Alter the Course of Mild to Moderate Asthma in Children and AdolescentsThe Journal of Pediatrics, 2009
- Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)Thorax, 2007